1-10 of 10
Danielle Shafer, DO
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Primary Ocular Lymphoma: A SEER Database Analysis of Patterns of Involvement and Outcomes

Arushi Khurana, MBBS, Taha Al-Juhaishi, MD, Victor Yazbeck, MD, Danielle Shafer, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 4013.
https://doi.org/10.1182/blood-2019-132011
Published: 2019
Journal Articles

Impact of Histologic Type on Survival in Primary Parotid Lymphomas

Taha Al-Juhaishi, MD, Arushi Khurana, MBBS, Danielle Shafer, DO, Victor Yazbeck, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5882.
https://doi.org/10.1182/blood-2019-130981
Published: 2019
Journal Articles

Favorable Outcomes of Acute Leukemia of Ambiguous Lineage Treated with Hypercvad: A Multi-Center Retrospective Study

Vu H. Duong, MD, Kebede H. Begna, MD, Kendra L. Sweet, MD, Eunice S. Wang, MD, Ryan James Caddell, PharmD, Danielle Shafer, DO, Zeba Singh, MBBS, Maria R. Baer, MD, Aref Al-Kali, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2658.
https://doi.org/10.1182/blood-2018-99-115448
Published: 2018
Journal Articles

Secondary Skin Involvement in Non-Hodgkin's Lymphoma Does Not Impact Outcomes: SEER Database Analysis

Arushi Khurana, MBBS, Taha Al-Juhaishi, MD, Danielle Shafer, DO
Journal: Blood
Blood (2018) 132 (Supplement 1): 2895.
https://doi.org/10.1182/blood-2018-99-120257
Published: 2018
Journal Articles

The Efficacy and Safety of the Addition of Rituximab to CHOP or a CHOP-Like Regimen In First Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): A Meta-Analysis

Aaron T Gerds, MD, Laura C Michaelis, MD, Danielle Shafer, DO
Journal: Blood
Blood (2010) 116 (21): 4913.
https://doi.org/10.1182/blood.V116.21.4913.4913
Published: 2010
Journal Articles

Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease.

Laura C Michaelis, MD, Danielle Shafer, DO, Kevin Barton, MD, Tulio Rodriguez, MD, Scott Smith, M.D., Ph.D, Patrick Stiff, MD, Sucha Nand, MD
Journal: Blood
Blood (2009) 114 (22): 1034.
https://doi.org/10.1182/blood.V114.22.1034.1034
Published: 2009
Journal Articles

CD4 Cell Count of More Than 250/Microl in the Peripheral Blood Is Associated with Improved Overall Survival in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Independent of the aaIPI

Hossein Borghaei, DO, MS, Mitchell Smith, MD, Ph.D., Michael Millenson, Tianyu Li, Danielle Shafer, DO, Tahseen I. Al-Saleem, MD
Journal: Blood
Blood (2008) 112 (11): 3775.
https://doi.org/10.1182/blood.V112.11.3775.3775
Published: 2008
Journal Articles

Peripheral Blood CD3 + CD4 + and CD3 − CD56 + Cell Counts and Circulating Lymphoma Cells Are Significant Predictors of Overall Survival in Newly Diagnosed Follicular Lymphoma.

Danielle Shafer, DO, Mitchell R. Smith, MD, PhD, Samuel Litwin, PhD, Tianyu Li, Hossein Borghaei, DO, Tahseen I. Al-Saleem, MD
Journal: Blood
Blood (2007) 110 (11): 2607.
https://doi.org/10.1182/blood.V110.11.2607.2607
Published: 2007
Journal Articles

Phase I Trial of Combination Therapy with 90 Y Ibritumomab Tiuxetan and Gemcitabine in Patients with Non-Hodgkin’s Lymphoma.

Hossein Borghaei, DO, MS, Mitchell Smith, MD, Ph.D., Michael Millenson, MD, Danielle Shafer, DO, Linda Thibodeau, RN, Russell Schilder, MD
Journal: Blood
Blood (2006) 108 (11): 4710.
https://doi.org/10.1182/blood.V108.11.4710.4710
Published: 2006
Journal Articles

Vinblastine, Mitoxantrone and Prednisone (MVP) Followed by Involved Field Radiotherapy (IF-XRT) for Early Clinical Stage Hodgkins’s Lymphoma: Long Term Follow-Up.

Danielle Shafer, DO, Hossein Borghaei, DO, Michael Millenson, MD, Nicos Nicolaou, MD, Tahseen I. Al-Saleem, MD, Nick C. Leasure, MD, Kris Padavic, RN, Mitchell R. Smith, MD, PhD, Russell J. Schilder, MD
Journal: Blood
Blood (2005) 106 (11): 2677.
https://doi.org/10.1182/blood.V106.11.2677.2677
Published: 2005